Search results
Growing demand for weight loss treatments drives sales at drugmaker Novo Nordisk
PA Media: Money via Yahoo Finance· 3 hours agoOzempic is a medicine designed to treat people with type 2 diabetes (Alamy/PA) Sales growth was...
Cardinal Health lifts 2024 profit view on demand for costly specialty drugs
Reuters· 49 minutes ago, opens new tab raised its annual profit forecast on Thursday, betting on strength in its pharmaceutical unit selling costly specialty drugs used to treat complex conditions such as cancer. ...
London Drugs closes stores after cyber incident
Supermarket News· 18 hours agoThe cybersecurity incident was the second breach at a major North American healthcare company in recent months following an attack in February at Change...
Lawsuit Funding Leader Launches New Page for Pharmaceutical Bad Drug Lawsuits
FOX 23 News Albany· 3 hours agoPre-Settlement Funding Firm has specialized in funding for pharmaceutical drug lawsuits for over a decade, and has an experienced team to handle high-intake requests for those ...
Novartis to buy radiology specialist Mariana Oncology for $1 billion
Reuters· 2 hours agoNovartis has entered an agreement to acquire US radiopharmaceutical company Mariana Oncology for $1...
Novo Nordisk Lifts Guidance as Blockbuster Drug Demand Shows No Signs of Abating
Morningstar· 7 hours agoBy Dominic Chopping Danish pharmaceutical giant Novo Nordisk raised full-year guidance to reflect better pricing in the U.S. and as global demand for its hit weight-loss and diabetes drugs continues ...
Ohio company gets greenlight from FDA to test Cuban drug for diabetic foot ulcers
The Cleveland Plain Dealer· 16 hours agoCLEVELAND, Ohio— Cleveland-based biotechnology company Discovery Therapeutics Caribe will soon be...
Why a legal fight against the manufacturers of Ozempic, Mounjaro, and other diabetes and weight-loss...
Philly.com· 5 hours agoThe patients live all over the country, but the lawsuits that play out in a Philadelphia courtroom...
These Stocks Are Moving the Most Today: Carvana, Fastly, Peloton, Wayfair, Qualcomm, Apple, Qorvo,...
Barrons.com· 42 minutes agoCarvana posts a surprise first-quarter profit, Fastly stock sinks after the company issues guidance...
Project Optimus: helping or hindering cancer drug development?
Clinical Trials Arena via Yahoo Finance· 6 hours agoSmaller companies may feel the brunt of the negative effects of this FDA initiative...extended...